Synthesis and antitumor evaluation of novel 5-substituted-4-hydroxy-8-nitroquinazolines as EGFR signaling-targeted inhibitors.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Bioorganic & Medicinal Chemistry

• Publication date

  2005-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.BMC.2005.05.045PMID 15993078
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protein tyrosine kinase inhibitors as anticancer agents

  2004cited by this paper
• Epidermal growth factor receptor tyrosine kinase inhibitors

  2004cited by this paper
• Synthesis and SAR of potent EGFR/erbB2 dual inhibitors.

  2004cited by this paper
• A Unique Structure for Epidermal Growth Factor Receptor Bound to GW572016 (Lapatinib)

  2004cited by this paper
• Tyrosine kinases as targets in cancer therapy – successes and failures

  2003cited by this paper
• Discovery and biological evaluation of potent dual ErbB-2/EGFR tyrosine kinase inhibitors: 6-thiazolylquinazolines.

  2003cited by this paper
• Comparison of the Biochemical and Kinetic Properties of the Type 1 Receptor Tyrosine Kinase Intracellular Domains

  2002cited by this paper
• Studies leading to the identification of ZD1839 (IRESSA): an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer.

  2001cited by this paper
• 6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinases with enhanced antitumor activity.

  2001cited by this paper
• Untangling the ErbB signalling network

  2001cited by this paper
• Chemical inhibitors of protein kinases.

  2001cited by this paper
• Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function

  1998cited by this paper
• ErbB‐2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling

  1997cited by this paper
• Tyrosine kinase inhibitors. 5. Synthesis and structure-activity relationships for 4-[(phenylmethyl)amino]- and 4-(phenylamino)quinazolines as potent adenosine 5'-triphosphate binding site inhibitors of the tyrosine kinase domain of the epidermal growth factor receptor.

  1995cited by this paper
• LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions.

  1995cited by this paper
• New colorimetric cytotoxicity assay for anticancer-drug screening.

  1990cited by this paper
• A NEW FORCE FIELD FOR MOLECULAR MECHANICAL SIMULATION OF NUCLEIC ACIDS AND PROTEINS

  1984cited by this paper
• ITERATIVE PARTIAL EQUALIZATION OF ORBITAL ELECTRONEGATIVITY – A RAPID ACCESS TO ATOMIC CHARGES

  1980cited by this paper

• Design and evaluation of pyridine-linked 1,3,4-oxadiazole-triazole heterocycles: a synthetic, computational and biological study

  2025cites this paper
• Distinct Selectivity of 2-Aryl Thioquinazolinones in the Sulfur Directing Rh(III)-Catalyzed Amidation Reaction.

  2025cites this paper
• Synthesis, Anticancer and Antiviral Activity Studies of 1,3,4-Oxadiazoles: A Review

  2022cites this paper
• 3,4-Dihydroquinazolin-8-yl-3-phenylurea Derivatives: Synthesis, VEGFR-2 Kinase Inhibiting Activity, and Molecular Docking

  2021cites this paper
• Design, synthesis and antibacterial activities of novel complexes of 3-Amino-2-Methyl-7-Chloro-Quinazolin 4 (3H)-One

  2020cites this paper
• Discovery of 6‐Arylurea‐2‐arylbenzoxazole and 6‐Arylurea‐2‐arylbenzimidazole Derivatives as Angiogenesis Inhibitors: Design, Synthesis and in vitro Biological Evaluation

  2019cites this paper
• Discovery of arylamide-5-anilinoquinazoline-8-nitro derivatives as VEGFR-2 kinase inhibitors: Synthesis, in vitro biological evaluation and molecular docking.

  2019cites this paper
• Synthesis and Anti-Inflammatory Activity of 4 ( 3 H )-Quinazolinone and Its 2-Methyl and 2-Phenyl-4 ( 3 H )-Quinazolinone Derivatives

  2018cites this paper
• Synthesis of Some Novel Quinazolinone Derivatives with Anticipated Biological Activity

  2017cites this paper
• Quinazolines and anticancer activity: A current perspectives

  2017cites this paper
• Review on EGFR Inhibitors: Critical Updates.

  2016cites this paper
• Antidepressant Activity of Some Novel 1, 2, 4 Triazole Substituted Quinazoline Derivatives

  2016cites this paper
• Synthesis, characterization, and toxicity of multi-walled carbon nanotubes functionalized with 4-hydroxyquinazoline

  2016cites this paper
• 1,3,4-Oxadiazoles: An emerging scaffold to target growth factors, enzymes and kinases as anticancer agents.

  2015cites this paper
• Synthesis and In-Vitro Cytotoxicity of (E)-N,2,3-Triarylacrylamide Derivatives as Analogs of Combretastatin A-4.

  2015cites this paper
• SYNTHESIS AND BIOLOGICAL EVALUATION OF SOME NOVEL ISOXAZOLINE DERIVATIVES OF CARBOSTYRIL

  2014cites this paper
• Synthesis, anticancer activity and structure-activity relationship of some anticancer agents based on cyclopenta (b) thiophene scaffold.

  2014cites this paper
• Indoxylic Acid Esters as Convenient Intermediates Towards Indoxyl Glycosides

  2014cites this paper
• SYNTHESIS AND BIOLOGICAL EVALUATION OF SOME NOVEL SCHIFF BASES OF 2-QUINOLONES

  2014cites this paper
• SYNTHESIS, ANTIMICROBIAL AND ANTI-INFLAMMATORY ACTIVITY OF NEWLY SYNTHESIZED ISOXAZOLINE INCORPORATED 2-QUINOLONES

  2014cites this paper
• Solvent/oxidant-switchable synthesis of multisubstituted quinazolines and benzimidazoles via metal-free selective oxidative annulation of arylamidines.

  2014cites this paper
• Synthesis, Antimicrobial and Anti-Inflammatory studies of some novel

  2014cites this paper
• Novel efficient routes to indoxyl glycosides for monitoring glycosidase activities.

  2013cites this paper
• Synthesis and antimicrobial activity of polyhalobenzonitrile quinazolin-4(3H)-one derivatives.

  2013cites this paper
• SYNTHESIS AND BIOLOGICAL EVALUATION OF SOME NOVEL PYRAZOLINE DERIVATIVES DERIVED FROM N - SUBSTITUTED QUINOLINYL CHALCONES

  2013cites this paper
• Novel 5-anilinoquinazoline-8-nitro derivatives as inhibitors of VEGFR-2 tyrosine kinase: synthesis, biological evaluation and molecular docking.

  2013cites this paper
• Synthesis and Preliminary Cytotoxicity Evaluation of New Diarylamides and Diarylureas Possessing 2,3-Dihydropyrrolo[3,2-b]quinoline Scaffold.

  2013cites this paper
• Quinazoline arylurea and preparation method and application thereof

  2012cites this paper
• Catalytic asymmetric α-amination of carboxylic acids using isothioureas

  2012cites this paper
• Synthesis and Anti-proliferative Activity of Substituted-Anilinoquinazolines and Its Relation to EGFR Inhibition

  2012cites this paper
• Synthesis and in vitro antitumor activity of substituted quinazoline and quinoxaline derivatives: search for anticancer agent.

  2011cites this paper
• Design, synthesis of novel quinazolone alkaloids derivatives as potential antitumor agents.

  2011cites this paper
• Novel diphenylamine 2,4'-dicarboxamide based azoles as potential epidermal growth factor receptor inhibitors: synthesis and biological activity.

  2011cites this paper
• An Improved Preparation of 4-Chloro-1H-indazole

  2011cites this paper
• Combined pharmacophore and structure-guided studies to identify diverse HSP90 inhibitors.

  2010cites this paper
• Synthesis of novel 2-quinolone derivatives

  2010cites this paper
• Triple molecular target approach to selective melanoma cytotoxicity.

  2010cites this paper
• Analytical and biological characterization of quinazoline semicarbazone derivatives

  2010cites this paper
• Synthesis, Spectroscopic and Antimicrobial Studies of Transition Metal Complexes of N-Amino Quinolone Derivatives

  2010cites this paper
• Synthesis and biological evaluation of novel 2,4'-bis substituted diphenylamines as anticancer agents and potential epidermal growth factor receptor tyrosine kinase inhibitors.

  2010cites this paper
• A Novel Synthetic Analog of 5, 8-Disubstituted Quinazolines Blocks Mitosis and Induces Apoptosis of Tumor Cells by Inhibiting Microtubule Polymerization

  2010cites this paper
• Computational studies of epidermal growth factor receptor: docking reliability, three-dimensional quantitative structure-activity relationship analysis, and virtual screening studies.

  2009cites this paper
• Receptor tyrosine kinase inhibitors as potent weapons in war against cancers.

  2009cites this paper
• Synthesis of quinazolines as tyrosine kinase inhibitors.

  2009cites this paper
• Design, synthesis and bioassay of novel metal complexes of 3-amino-2-methylquinazolin-4(3H)-one

  2009cites this paper
• Design, synthesis and in vitro antitumor activity of 4-aminoquinoline and 4-aminoquinazoline derivatives targeting EGFR tyrosine kinase.

  2008cites this paper
• Pyrimidines and their Benzo Derivatives

  2008cites this paper
• Discovery of novel small-molecule inhibitors of human epidermal growth factor receptor-2: combined ligand and target-based approach.

  2008cites this paper
• Design, synthesis and biological evaluation of substituted pyrrolo[2,3-d]pyrimidines as multiple receptor tyrosine kinase inhibitors and antiangiogenic agents.

  2008cites this paper
• Synthesis and antifungal bioactivities of 3-alkylquinazolin- 4-one derivatives.

  2006cites this paper
• Synthesis And Antimicrobial Activity Of Some Annelated Quinazoline Derivatives

  2006cites this paper
• Design, synthesis and antitumor evaluation of a new series of N-substituted-thiourea derivatives

  2006cites this paper
• 4'-Alkoxyl substitution enhancing the anti-mitotic effect of 5-(3',4',5'-substituted)anilino-4-hydroxy-8-nitroquinazolines as a novel class of anti-microtubule agents.

  2006cites this paper